 | Up a level |
Jump to: 2022
Number of items: 1.
2022
Muinos-Buehl, A., Rombo, R., Janzen, E., Ling, K. K., Hupperich, K., Rigo, F., Bennett, C. F. and Wirth, B. (2022). Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks. Neurobiol. Dis., 171. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1095-953X